Determination of hearing threshold in children with and without type 1 diabetes mellitus: a case-control study in

Fatemeh Nasrollahtabar1, Fereshteh Bagheri2, Hadis Ebrahimzadeh3

  • 1Student Research Committee, Babol University of Medical Sciences, Babol, Iran.

Insights

Type 1 Diabetes Mellitus (T1DM) in children is linked to auditory abnormalities, affecting hearing thresholds. Early detection and management are crucial for preventing hearing impairment associated with T1DM.

Area of Science:

  • Pediatric Endocrinology
  • Audiology
  • Otolaryngology

Background:

  • Type 1 Diabetes Mellitus (T1DM) can lead to complications affecting inner ear function in children, potentially causing hearing impairment.
  • Limited research exists on the specific impact of T1DM on hearing levels in pediatric populations.

Purpose of the Study:

  • To evaluate hearing thresholds in children with and without T1DM.
  • To investigate the relationship between T1DM and auditory function in children.

Main Methods:

  • A case-control study involving children aged 6-18 years.
  • Hearing assessments included tympanometry, auditory brainstem response (ABR), and pure-tone audiometry (PTA).
  • Data were analyzed using SPSS, with statistical significance set at P < 0.05.

Main Results:

  • Significant differences in ABR results (wave latencies and interwave intervals) were observed between children with T1DM and controls in both ears.
  • A weak but significant correlation was found between T1DM duration and auditory brainstem response in the right ear.
  • The study included 41 children with T1DM and 44 healthy controls.

Conclusions:

  • Type 1 Diabetes Mellitus is associated with auditory abnormalities in children.
  • Hearing impairment in children with T1DM may be linked to disease duration and metabolic control levels.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...